Replies to post #2183 on Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[RichDude]

Generx has been evaluated in studies of over 650 patients (including 450 Generx-treated patients) in four multi-center, double-blind, placebo-controlled clinical studies at 100 medical centers. Generx is the most clinically advanced DNA-based cardiovascular angiogenic growth factor therapeutic in the world.

[RichDude]

CRXM presented phase 3 Angiogenic Gene Therapy clinical update at the 11th annual Cell & Gene Therapy forum, in January. Have a look at some of the participants, from BIG PHARMA:

http://www.bioleaders-forum.com/files/phacilitate_washington_2015__main_announcement.pdf

They are also presenting at many other forums.

Can you say, LOOKING FOR A BUYER?!